Skip navigation
  • DSpace logo
  • Home
  • Collections
  • Research Outputs
  • Author profiles
  • Departments & Affiliations
  • Explore by
    • Research Outputs
    • Author profiles
    • Departments & Affiliations
  • Login or register:
    • My NSLHD
    • Receive email
      updates
    • Edit Account details

  1. NSLHD Research
  2. Research
  3. Research Publications
Please use this identifier to cite or link to this item: https://nslhd.intersearch.com.au/nslhdjspui/handle/1/42913
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHarbeck, Nadiaen
dc.contributor.authorCiruelos, Evaen
dc.contributor.authorJerusalem, Guyen
dc.contributor.authorMüller, Volkmaren
dc.contributor.authorNiikura, Naokien
dc.contributor.authorViale, Giuseppeen
dc.contributor.authorBartsch, Ruperten
dc.contributor.authorKurzeder, Christianen
dc.contributor.authorHiggins, Michaela Jen
dc.contributor.authorConnolly, Roisin Men
dc.contributor.authorBaron-Hay, Sally Een
dc.contributor.authorGión, Maríaen
dc.contributor.authorGuarneri, Valentinaen
dc.contributor.authorBianchini, Giampaoloen
dc.contributor.authorWildiers, Hansen
dc.contributor.authorEscrivá-de-Romaní, Santiagoen
dc.contributor.authorPrahladan, Manojen
dc.contributor.authorBridge, Helenen
dc.contributor.authorKuptsova-Clarkson, Nataliyaen
dc.contributor.authorScotto, Nanaen
dc.contributor.authorVerma, Sunilen
dc.contributor.authorLin, Nancy Uen
dc.date.accessioned2025-01-12T23:53:36Z-
dc.date.available2025-01-12T23:53:36Z-
dc.date.issued2024-12-
dc.identifier.citation30(12):3780en
dc.identifier.issn1546-170X-
dc.identifier.urihttps://nslhd.intersearch.com.au/nslhdjspui/handle/1/42913-
dc.language.isoenen
dc.relation.ispartofNature Medicineen
dc.titlePublisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trialen
dc.typeOtheren
dc.identifier.affiliationBreast Center, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Munich, LMU University Hospital, Munich, Germany. nadia.harbeck@med.uni-muenchen.de.en
dc.identifier.affiliationHospital Universitario 12 de Octubre, Madrid, Spain.en
dc.identifier.affiliationCHU Liège and Liège University, Liège, Belgium.en
dc.identifier.affiliationUniversity Medical Center Hamburg-Eppendorf, Hamburg, Germany.en
dc.identifier.affiliationTokai University School of Medicine, Kanagawa, Japan.en
dc.identifier.affiliationDepartment of Pathology and Laboratory Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy.en
dc.identifier.affiliationDivision of Oncology, Department of Medicine 1, Medical University of Vienna, Vienna, Austria.en
dc.identifier.affiliationBreast Center, University Hospital Basel, Basel, Switzerland.en
dc.identifier.affiliationSt. Vincent's University Hospital, UCD Cancer Trials Cluster, Dublin, Ireland.en
dc.identifier.affiliationCancer Research @UCC, College of Medicine and Health, University College Cork, Cork, Ireland.;Cancer Trials Cork, CUH/UCC Cancer Center, Cork University Hospital, Cork, Ireland.en
dc.identifier.affiliationRoyal North Shore Hospitalen
dc.identifier.affiliationIOB-Madrid, Beata María Ana Hospital, Madrid, Spain.;Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain.en
dc.identifier.affiliationDepartment of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.;Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy.en
dc.identifier.affiliationDepartment of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.;School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.en
dc.identifier.affiliationDepartment of General Medical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.en
dc.identifier.affiliationVall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.en
dc.identifier.affiliationGlobal Medical Affairs, Oncology R&D, AstraZeneca, Cambridge, UK.en
dc.identifier.affiliationOncology Global Medical Affairs / Payer Biometrics, AstraZeneca, Macclesfield, UK.en
dc.identifier.affiliationPatient Safety, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.en
dc.identifier.affiliationOncology Global Medical Affairs, AstraZeneca, Baar, Switzerland.en
dc.identifier.affiliationOncology Franchise, AstraZeneca, Gaithersburg, MD, USA.en
dc.identifier.affiliationDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.en
dc.identifier.doi10.1038/s41591-024-03349-0-
dc.description.pages3780en
dc.relation.urlhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11645286/en
local.editedby.nameHN130125en
dc.identifier.pmid39653780-
dc.relation.departmentMedical Oncologyen
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairetypeOther-
item.grantfulltextnone-
item.cerifentitytypePublications-
crisitem.author.deptOncology-
crisitem.author.deptRoyal North Shore Hospital-
Appears in Collections:Research Publications
Show simple item record

Page view(s)

2
checked on Jan 15, 2025
Find this article in Springboard

Google ScholarTM

Check

Altmetric


Items in NSLHD are protected by copyright, with all rights reserved, unless otherwise indicated.

Northern Sydney Local Health District   |   Northern Sydney Local Health District Libraries  |   NSLHD Springboard   |   Contact the Library